Piracetam

Application area

Symptomatic treatment of intellectual-mnestic disorders in the absence of a proven diagnosis of dementia. Reducing the manifestations of cortical myoclonus in patients sensitive to piracetam, both as monotherapy and as part of combination therapy. (A trial course of treatment can be carried out to determine the sensitivity to piracetam in a particular case).